Acyclovir susceptibility and genetic characteristics of sequential herpes simplex virus type 1 corneal isolates from patients with recurrent herpetic keratitis

Journal of Infectious Diseases

Volumn 200, Issue 9, 2009, Pages 1402-1414

  Duan, Rui ^a,b   De Vries, Rory D ^a   Van Dun, Jessica M ^a   Van Loenen, Freek B ^a,b   Osterhaus, Albert D M E ^a   Remeijer, Lies ^b   Verjans, Georges M G M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ROTTERDAM EYE HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; THYMIDINE KINASE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA; CORRELATION ANALYSIS; DNA POLYMORPHISM; FEMALE; GENETIC ANALYSIS; GENOTYPE; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; HUMAN; IMMUNOCOMPETENCE; INCIDENCE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; RECURRENT DISEASE; UNINDEXED SEQUENCE; VIRUS ISOLATION;

ACYCLOVIR; ADULT; AGED; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; HERPESVIRUS 1, HUMAN; HUMANS; KERATITIS, HERPETIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VIRUS LATENCY;

EID: 72849122362     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/606028     Document Type: Article

References (41)

1. Roizman B, Knipe DM, Whitley RJ. Herpes simplex viruses. In: Knipe DM, Howley P, eds. Fields virology. Philadelphia: Lippincott Williams and Wilkins, 2007; 2502-2576
2. Liesegang TJ. Herpes simplex virus epidemiology and ocular importance. Cornea 2001; 20:1-13. (Pubitemid 32038147) (Pubitemid 32038147)
3. Remeijer L, Osterhaus AD, Verjans GM. Human herpes simplex virus keratitis: the pathogenesis revisited. Ocul Immunol Inflamm 2004; 12: 255-285 (Pubitemid 40138184) (Pubitemid 40138184)
4. Remeijer L, Maertzdorf J, Buitenwerf J, Osterhaus AD, Verjans GM. Corneal herpes simplex virus type 1 superinfection in patients with recrudescent herpetic keratitis. Invest Ophthalmol Vis Sci 2002; 43:358-363 (Pubitemid 34113215)
5. Herpetic Eye Disease Study Group. Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis. Arch Ophthalmol 2000; 118:1030-1036
6. Rezende RA, Bisol T, Hammersmith K, et al. Efficacy of oral antiviral prophylaxis in preventing ocular herpes simplex virus recurrences in patients with and without self-reported atopy. Am J Ophthalmol 2006; 142:563-567
7. Naesens L, De Clercq E. Recent developments in herpesvirus therapy. Herpes 2001; 8:12-16
8. Bacon TH, Levin MJ, Leary JJ, Sarisky RT, Sutton D. Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Clin Microbiol Rev 2003; 16:114-128 (Pubitemid 36114710) (Pubitemid 36114710)
9. Stránská R, Schuurman R, Nienhuis E, et al. Survey of acyclovir-esistant herpes simplex virus in the Netherlands: prevalence and characterization. J Clin Virol 2005; 32:7-18. (Pubitemid 39575009) (Pubitemid 39575009)
10. 0. Danve-Szatanek C, Aymard M, Thouvenot D, et al. Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. J Clin Microbiol 2004; 42:242-249 (Pubitemid 38082727) (Pubitemid 38082727)
11. Morfin F, Thouvenot D. Herpes simplex virus resistance to antiviral drugs. J Clin Virol 2003; 26:29-37. (Pubitemid 36183346) (Pubitemid 36183346)
12. Chibo D, Druce J, Sasadeusz J, Birch C. Molecular analysis of clinical isolates of acyclovir resistant herpes simplex virus. Antiviral Res 2004; 61:83-91. (Pubitemid 37506095) (Pubitemid 37506095)
13. Frobert E, Cortay JC, Ooka T, et al. Genotypic detection of acyclovir-resistant HSV-1: characterization of 67 ACV-sensitive and 14 ACV-resistant viruses. Antiviral Res 2008; 79:28-36.
14. Duan R, de Vries RD, Osterhaus AD, Remeijer L, Verjans GM. Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis. J Infect Dis 2008; 198:659-663
15. Liesegang TJ. Classification of herpes simplex virus keratitis and anterior uveitis. Cornea 1999; 18:127-143 (Pubitemid 29159255) (Pubitemid 29159255)
16. Holland EJ, Schwartz GS. Classification of herpes simplex virus keratitis. Cornea 1999; 18:144-154 (Pubitemid 29159256)
17. Thi TN, Deback C, Malet I, Bonnafous P, Ait-Arkoub Z, Agut H. Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR. Antiviral Res 2006; 69:152-157 (Pubitemid 43247335) (Pubitemid 43247335)
18. Shin YK, Cai GY, Weinberg A, Leary JJ, Levin MJ. Frequency of acyclovir-resistant herpes simplex virus in clinical specimens and laboratory isolates. J Clin Microbiol 2001; 39:913-917 (Pubitemid 32209699) (Pubitemid 32209699)
19. Maertzdorf J, Remeijer L, Van Der Lelij A, et al. Amplification of reiterated sequences of herpes simplex virus type 1 (HSV-1) genome to discriminate between clinical HSV-1 isolates. J Clin Microbiol 1999; 37:3518-3523 (Pubitemid 29491085)
20. Sarisky RT, Nguyen TT, Duffy KE, Wittrock RJ, Leary JJ. Difference in incidence of spontaneous mutations between herpes simplex virus types 1 and 2. Antimicrob Agents Chemother 2000; 44:1524-1529 (Pubitemid 30340789) (Pubitemid 30340789)
21. Chen Y, Scieux C, Garrait V, et al. Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation. Clin Infect Dis 2000; 31:927-935 (Pubitemid 32299349) (Pubitemid 32299349)
22. Levin MJ, Bacon TH, Leary JJ. Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients. Clin Infect Dis 2004; 39:S248-57.
23. Oram RJ, Marcellino D, Strauss D, et al. Characterization of an acyclovir-resistant herpes simplex virus type 2 strain isolated from a premature neonate. J Infect Dis 2000; 181:1458-1461 (Pubitemid 30252555) (Pubitemid 30252555)
24. Levin MJ, Weinberg A, Leary JJ, Sarisky RT. Development of acyclovirresistant herpes simplex virus early during the treatment of herpes neonatorum. Pediatr Infect Dis J 2001; 20:1094-1097 (Pubitemid 33055088) (Pubitemid 33055088)
25. Lepisto AJ, Frank GM, Hendricks RL. How herpes simplex virus type 1 rescinds corneal privilege. Chem Immunol Allergy 2007; 92:203-212 (Pubitemid 47096909)
26. Gilbert C, Bestman-Smith J, Boivin G. Resistance of herpesviruses toantiviral drugs: clinical impacts and molecular mechanisms. Drug Resist Updat 2002; 5:88-114. (Pubitemid 35024271) (Pubitemid 35024271)
27. Gaudreau A, Hill E, Balfour HH Jr, Erice A, Boivin G. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients. J Infect Dis 1998; 178:297-303. (Pubitemid 28347909)
28. Stránská R, van Loon AM, Polman M, et al. Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients. Antivir Ther 2004; 9:565-575 (Pubitemid 39150214)
29. Jamieson AT, Gentry GA, Subak-Sharpe JH. Induction of both thymidine and deoxycytidine kinase activity by herpes viruses. J Gen Virol 1974; 24:465-480
30. Tenser RB, Ressel S, Dunstan ME. Herpes simplex virus thymidine kinase expression in trigeminal ganglion infection: correlation of enzyme activity with ganglion virus titer and evidence of in vivo complementation. Virology 1981; 112:328-341 (Pubitemid 11069784) (Pubitemid 11069784)
31. Chen SH, Pearson A, Coen DM, Chen SH. Failure of thymidine kinasenegative herpes simplex virus to reactivate from latency following efficient establishment. J Virol 2004; 78:520-523 (Pubitemid 37549763) (Pubitemid 37549763)
32. Shimada Y, Suzuki M, Shirasaki F, et al. Genital herpes due to acyclovirsensitive herpes simplex virus caused secondary and recurrent herpetic whitlows due to thymidine kinase-deficient/temperature-sensitive virus. J Med Virol 2007; 79:1731-1740 (Pubitemid 47479891) (Pubitemid 47479891)
33. Palú G, Gerna G, Bevilacqua F, Marcello A. A point mutation in the thymidine kinase gene is responsible for acyclovir-resistance in herpes simplex virus type 2 sequential isolates. Virus Res 1992; 25:133-144
34. Kost RG, Hill EL, Tigges M, Straus SE. Recurrent acyclovir-resistant genital herpes in an immunocompetent patient. N Engl J Med 1993; 329:1777-1782 (Pubitemid 23355551) (Pubitemid 23355551)
35. Saijo M, Suzutani T, Itoh K, et al. Nucleotide sequence of thymidine kinase gene of sequential acyclovir-resistant herpes simplex virus type 1 isolates recovered from a child with Wiskott-Aldrich syndrome: evidence for reactivation of acyclovir-resistant herpes simplex virus. JMed Virol 1999; 58:387-393 (Pubitemid 29326053) (Pubitemid 29326053)
36. Morfin F, Thouvenot D, Aymard M, Souillet G. Reactivation of acyclovir-resistant thymidine kinase-deficient herpes simplex virus harbouring single base insertion within a 7 Gs homopolymer repeat of the thymidine kinase gene. J Med Virol 2000; 62:247-250 (Pubitemid 30688692)
37. Wang K, Mahalingam G, Hoover SE, et al. Diverse herpes simplex virus type 1 thymidine kinase mutants in individual human neurons and ganglia. J Virol 2007; 81:6817-6826 (Pubitemid 46986618) (Pubitemid 46986618)
38. Hwang CB, Horsburgh B, Pelosi E, Roberts S, Digard P, Coen DM. A net +1 frameshift permits synthesis of thymidine kinase from a drugresistant herpes simplex virus mutant. Proc Natl Acad Sci U S A 1994; 91:5461-5465 (Pubitemid 24174347) (Pubitemid 24174347)
39. Griffiths A, Link MA, Furness CL, Coen DM. Low-level expression and reversion both contribute to reactivation of herpes simplex virus drug-resistant mutants with mutations on homopolymeric sequences in thymidine kinase. J Virol 2006; 80:6568-6574 (Pubitemid 43927458) (Pubitemid 43927458)
40. Efstathiou S, Kemp S, Darby G, Minson AC. The role of herpes simplex virus type 1 thymidine kinase in pathogenesis. J Gen Virol 1989;70: 869-879 (Pubitemid 19099636)
41. Chen SH, Lin YW, Griffiths A, Huang WY, Chen SH. Competition and complementation between thymidine kinase-negative and wildtype herpes simplex virus during co-infection of mouse trigeminal ganglia. J Gen Virol 2006; 87:3495-3502 (Pubitemid 44816982) (Pubitemid 44816982)